Oral Clinical Nutrition Market by Stage (Adults and Pediatrics), Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, and Others), Sales Channel (Online Sales, Retail Sales, and Institutional Sales), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032

Oral Clinical Nutrition Overview

Oral clinical nutrition refers to the application of nutritional science in a clinical setting, focusing on assessing, diagnosing, and managing nutritional issues through oral intake methods. This field involves the study of nutrients in food, their digestion, absorption, metabolism, and how they impact overall health and well-being. These conditions may include malnutrition, chronic illnesses, swallowing difficulties, or other issues affecting normal food consumption. Prescribed by healthcare professionals, such as dietitians or physicians, oral clinical nutrition products are tailored to meet the individual patient's requirements and come in various forms, like liquids, powders, or bars. The main objectives of oral clinical nutrition are to improve nutritional status, support recovery, manage specific medical conditions, and address swallowing difficulties in patients.

Global Oral Clinical Nutrition Market Analysis

The global oral clinical nutrition market size was $15.64 billion in 2022 and is predicted to grow at a CAGR of XX%, by generating a revenue of $XX billion by 2032.

COVID-19 Impact on Global Oral Clinical Nutrition Market

The COVID-19 pandemic had a significant impact on the oral clinical nutrition market. One notable effect was the increased demand for immune support products, as people became more conscious of maintaining their immune health in the face of the respiratory illness caused by the novel coronavirus. Disruptions in global supply chains due to lockdowns, transportation restrictions, and labor shortages also affected the production and distribution of oral clinical nutrition products, leading to potential shortages and delays in supply. Healthcare priorities shifted during the pandemic, diverting resources towards combating COVID-19 and potentially delaying non-essential medical treatments, including some oral clinical nutrition interventions.

Additionally, the pandemic influenced distribution channels, with increased reliance on e-commerce and home delivery services for accessing healthcare products while minimizing exposure to the virus. Clinical trials for new oral clinical nutrition products were delayed or disrupted, impacting the introduction of new products into the market. Economic uncertainties during the pandemic led to financial constraints for individuals and healthcare facilities, influencing consumers' purchasing behavior and adopting oral clinical nutrition interventions.

Growing Aging Population to Drive the Market Growth

The oral clinical nutrition market is driven by several key factors. Firstly, the increasing aging population worldwide has increased and the incidence of chronic diseases, necessitating specialized oral clinical nutrition products. Secondly, the prevalence of chronic illnesses like diabetes, cancer, and cardiovascular diseases has expanded, creating a higher demand for nutrition-based interventions. Thirdly, developing awareness of nutrition's role in healthcare has emphasized the significance of oral clinical nutrition in managing various medical conditions. Additionally, technological advancements have resulted in innovative products available in different forms, catering to diverse patient needs. Furthermore, rising healthcare expenditures and favorable government policies and regulations have contributed to market growth. The shift towards home-based healthcare services has also boosted the demand for convenient and effective oral clinical nutrition products. Moreover, increasing health consciousness and wellness trends have encouraged individuals to manage their nutrition proactively. Finally, strategic marketing efforts and awareness campaigns have promoted the benefits of oral clinical nutrition, further driving market expansion.

Limited Awareness and Education to Restrain the Market Growth  

Several factors have restrained the oral clinical nutrition market. Awareness among patients and healthcare providers about the benefits and availability of oral clinical nutrition products can help adoption rates. Additionally, the high cost of these products compared to regular food items and inadequate insurance coverage can discourage some patients from regular usage. The limited product variety may make it challenging to meet the diverse nutritional needs of various patient groups, impacting further expansion. Moreover, strict regulatory requirements and challenges in obtaining necessary approvals can be time-consuming and costly for companies in this market. Intense competition among established players and new entrants can lead to pricing pressures and reduced profit margins. Adherence issues, patient skepticism, and the availability of alternative nutrition support methods can also contribute to the restraints. Furthermore, limited distribution channels and economic fluctuations may hinder the accessibility and demand for oral clinical nutrition products. Addressing these challenges would require collaborative efforts from various stakeholders to improve awareness, affordability, product variety, and distribution, potentially leading to further growth and advancements in oral clinical nutrition.

Prevalence of Malnutrition to Drive Excellent Opportunities

The oral clinical nutrition market has been experiencing substantial growth, driven by several key opportunities. First and foremost, the prevalence of malnutrition, especially in developing countries, has created a significant market for oral nutritional supplements that can effectively address this concern. The incidence of chronic diseases is also on the rise, necessitating tailored nutrition plans that oral clinical nutrition products can provide. Technological advancements have played a crucial role in improving the formulations and palatability of these products, increasing consumer acceptance and compliance. Moreover, the growth of healthcare expenditure and the expansion of online retail platforms have further facilitated the accessibility of oral clinical nutrition products to a wider consumer base. Lastly, the trend toward personalized medicine has driven interest in customized oral clinical nutrition offerings, providing a unique advantage for companies in this evolving market.

Global Oral Clinical Nutrition Market Share, by Stage, 2022

The adults sub-segment accounted for the highest market share in 2022. Adults have dominated the oral clinical nutrition market for several reasons. Firstly, adults are more likely to suffer from health conditions that require nutritional support, such as malnutrition, cancer, and gastrointestinal disorders. Consequently, the market has focused on catering to the specific needs of adult populations. Secondly, research and development efforts in the sector have prioritized adult populations, validating the efficacy and safety of these products for their needs. With a more extensive population base, the adult market presents a more profitable and attractive customer pool for companies to focus on. Additionally, navigating the regulatory landscape for pediatric use can take more work, leading manufacturers to concentrate on adult-focused products.

Global Oral Clinical Nutrition Market Share, by Indication, 2022

The cancer care sub-segment accounted for the highest market share in 2022. Cancer care has exerted a dominant influence on the oral clinical nutrition market for several compelling reasons. Firstly, the high demand from cancer patients seeking nutritional support has been a driving force. As cancer often leads to malnutrition and weight loss, oral clinical nutrition products, ranging from supplements to specialized formulations, have become essential in meeting increased nutritional needs and bolstering patients' overall health during treatment. Additionally, with the prevalence of cancer cases rising, the demand for these products has surged accordingly. Moreover, cancer treatments can tax the body, causing reduced appetite and nutrient absorption issues, making oral clinical nutrition products vital in providing essential nutrients and calories to support patients' strength and quality of life throughout treatment. The convenience and accessibility of these products, available in various forms, further contribute to their prominence in cancer care. As nutritional research highlights the benefits of personalized nutrition, cancer care providers have recognized the value of tailored nutrition plans, leading to greater adoption of oral clinical nutrition products. This approach aligns with the trend towards multidisciplinary and supportive cancer care, where oral clinical nutrition aids in improving patient outcomes and managing treatment side effects. Furthermore, extensive marketing efforts and awareness campaigns by the pharmaceutical and healthcare industries have significantly promoted the use of oral clinical nutrition products for cancer patients.

Global Oral Clinical Nutrition Market Share, by Sales Channel, 2022

The institutional sales sub-segment accounted for the highest market share in 2022. Institutional sales have been the dominant force in the oral clinical nutrition market for several vital reasons. Firstly, healthcare facilities such as hospitals and nursing homes represent the primary target market for oral clinical nutrition products due to their large patient populations with specific nutritional needs. Additionally, institutional sales follow established distribution channels that allow for efficient bulk purchases, making it convenient for these entities to acquire the necessary products. Secondly, medical professionals, including doctors and dietitians, wield significant influence in recommending and prescribing these products to patients in institutional settings, contributing to higher adoption rates. Moreover, the strict regulations and quality standards governing oral clinical nutrition products are often better addressed through institutional sales, offering reassurance and compliance to healthcare facilities. Long-term contractual agreements between manufacturers and institutions provide stability and continuity in the supply of products. Lastly, the purchasing power of institutions allows for more favorable negotiations with manufacturers, potentially reducing costs.

Global Oral Clinical Nutrition Market Share, by Region, 2022

The North America oral clinical nutrition market generated the highest revenue in 2022. North America has dominated the oral clinical nutrition market due to several key factors. The region's advanced healthcare infrastructure, including well-established hospitals and clinics, has facilitated the efficient distribution and accessibility of oral clinical nutrition products to patients. Moreover, North America's prominence in medical research and development has led to a constant stream of innovative solutions, attracting domestic and international customers. The region's high prevalence of chronic diseases, such as diabetes and obesity, has produced significant demand for oral clinical nutrition products to manage these conditions effectively. Moreover, a large aging population has expanded the need for specialized clinical nutrition to address age-related health challenges. The region's stringent regulatory framework and strong healthcare reimbursement policies have instilled confidence in healthcare professionals and patients, driving widespread adoption of these products. Finally, North America's robust distribution channels and consumer health and nutrition awareness have contributed to the region's dominant position in the oral clinical nutrition market.

Competitive Scenario in the Global Oral Clinical Nutrition Market

Investment and agreement are common strategies followed by major market players. One of the leading market players in the industry is Nestle S.A. In August 2019, Nestlé Health Science acquired Persona, a personalized vitamin business company. Through this acquisition, the company would expand its business in the customized nutrition segment.

Some of the leading oral clinical nutrition market players are Abbott Laboratories, Pfizer Inc., Bayer AG, Nestle S.A., GlaxoSmithKline plc, Baxter International Inc., Otsuka Holdings Co., Ltd., Mead Johnson & Company, LLC, Danone Nutricia, and Victus, Inc.